Amydis Developing Test to Measure TDP-43 Protein in Eye's Retina |... - ALS News Today

Amydis plans to launch a Phase 1/2a clinical trial to test a tracer that will measure TDP-43 protein deposits in the retina.

Amydis is developing a test to monitor the buildup of TDP-43 in the eye’s retina of people with amyotrophic lateral sclerosis (ALS), which could offer a noninvasive way to diagnose the neurodegenerat… [+3385 chars]

full article...